메뉴 건너뛰기




Volumn 27, Issue 9, 2008, Pages 818-822

Improvement of adherence in MS therapy - Results of an MS therapy support study;Steigerung der therapietreue durch ein therapie-begleitprogramm bei multipler sklerose

(335)  Ries, Stefan a,b   Elias, W G a   Japp, G a   Lang, M a   Bergmann, Arnfin a   Bischoff, Christian a   Hofmann, Werner a   Kausch, Ulrich a   Lang, Michael a   Reifschneider, Gerd a   Mager, a   Weber, a   Albrecht, a   Butz, a   Bittkau, Foroogh a   Bode, a   Pfeffer, a   Bodenschatz, a   Tröger, Jens a   Bohr, a   more..

a NONE
b NONE   (Germany)

Author keywords

Adherence; Interferon beta; MS nurse; Relapsing remitting multiple sclerosis; Treatment support

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; GLATIRAMER; IMMUNOGLOBULIN; INTERFERON BETA SERINE;

EID: 52449117935     PISSN: 07221541     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1627223     Document Type: Article
Times cited : (4)

References (10)
  • 2
    • 0037154192 scopus 로고    scopus 로고
    • Disease modifying therapies in multiple sclerosis: Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
    • Goodin DS et al. Disease modifying therapies in multiple sclerosis: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002;58:169-178.
    • (2002) Neurology , vol.58 , pp. 169-178
    • Goodin, D.S.1
  • 3
    • 52449111610 scopus 로고    scopus 로고
    • Internal Patient Data (DMD-Monitor) 2005.
    • Internal Patient Data (DMD-Monitor) 2005.
  • 4
    • 33847258713 scopus 로고    scopus 로고
    • Costs and quality of life of multiple sclerosis
    • Kobelt G et al. Costs and quality of life of multiple sclerosis. Eur J Health Econ 2006; 7 (Suppl 2):34-44.
    • (2006) Eur J Health Econ , vol.7 , Issue.SUPPL. 2 , pp. 34-44
    • Kobelt, G.1
  • 5
    • 0031947429 scopus 로고    scopus 로고
    • Economic evaluation of multiple sclerosis in the UK, Germany and France
    • Murphy N et al. Economic evaluation of multiple sclerosis in the UK, Germany and France. Pharmacoeconomics 1998; 13 (5 Pt 2): 607-622.
    • (1998) Pharmacoeconomics , vol.13 , Issue.5 PART 2 , pp. 607-622
    • Murphy, N.1
  • 6
  • 9
    • 52449114878 scopus 로고    scopus 로고
    • Therapie-Compliance. Ärztlicher Beirat des DMSG Bundesverbandes gibt Empfehlungen.
    • Toyka KV, Rieckmann P, Gold R. Therapie-Compliance. Ärztlicher Beirat des DMSG Bundesverbandes gibt Empfehlungen. Aktiv Fachzeitschrift der DMSG 2004; 204: 17-18.
    • (2004) Aktiv Fachzeitschrift der DMSG , vol.204 , pp. 17-18
    • Toyka, K.V.1    Rieckmann, P.2    Gold, R.3
  • 10
    • 0042932742 scopus 로고    scopus 로고
    • Interrupted therapy: Stopping and switching of the beta-interferons prescribed for MS
    • Tremlett H, Oger J. Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS. Neurology 2003; 4: 551-554.
    • (2003) Neurology , vol.4 , pp. 551-554
    • Tremlett, H.1    Oger, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.